| ACE-I | angiotensin converting enzyme inhibitor |
| AF | atrial fibrillation |
| ALT | alanine aminotransferase |
| AMP | adenosine monophosphate |
| AMPK 5′ | AMP-activated protein kinase |
| ARB | angiotensin receptor blocker |
| AST | aspartate aminotransferase |
| BMI | body mass index |
| CKD | chronic kidney disease |
| CRP | C-reactive protein |
| CT | computed tomography |
| CVD | cardiovascular diseases |
| DM | diabetes mellitus |
| eGFR | estimated glomerular filtration rate |
| FFA | free fatty acids |
| GGT | gamma-glutamyl transferase |
| HCC | hepatocellular carcinoma |
| HDL | high-density lipoprotein |
| IHTG | intra-hepatic accumulation of triglycerides |
| IL | interleukin |
| LPS | Lipopolysaccharide |
| LDL | low-density lipoprotein |
| MRT | magnetic resonance tomography |
| NAFL | non-alcoholic fatty liver |
| NAFLD | non-alcoholic fatty liver disease |
| NASH | non-alcoholic steatohepatitis |
| NF-κB | protein kinase C-delta (PKC-δ) and nuclear factor kinase-B |
| OSA | obstructive sleep apnea |
| PNPLA3 | patatin-like phospholipase domain-containing protein-3 |
| QTc | corrected QT interval |
| RAAS | renin-angiotensin-aldosterone system |
| ROS | reactive oxygen species |
| SGLT2 | sodium glucose cotrasporter type-2 |
| TMAO | trimethylamine-N-oxide |
| TNF-α | tumor necrosis factor alpha |
| VLDL | very low-density lipoprotein |